Terry and coworkers, in a case-control study with 1442 patients and 1420 controls, demonstrated a reduction in the risk of estrogen receptor-positive breast cancer with aspirin, finding a correlation between the use of NSAIDs and the non-development of this type of cancer [34]. This evidence concerns the gene ESR1 and cancer.